✦ LIBER ✦

Irreversible pan-ErbB tyrosine kinase inhibitors and breast cancer: Current status and future directions

✍ Scribed by Alberto Ocaña; Eitan Amir

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast cancer chemoprevention: Current s

✍ D.Lawrence Wickerham; Elizabeth Tan-Chiu 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 799 KB

Triple-negative breast cancer--current s

✍ Gluz, O.; Liedtke, C.; Gottschalk, N.; Pusztai, L.; Nitz, U.; Harbeck, N. 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 152 KB

Exemestane in Breast Cancer: Current Sta

✍ Per E. Lønning 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 119 KB

Current Status and Future Directions in

✍ Clifford A. Hudis 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 197 KB

Src Inhibitors in Lung Cancer: Current S

✍ Sacha I. Rothschild; Oliver Gautschi; Eric B. Haura; Faye M. Johnson 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 102 KB

Tyrosine Kinase Inhibitors of Vascular E

✍ Morabito, A.; De Maio, E.; Di Maio, M.; Normanno, N.; Perrone, F. 📂 Article 📅 2006 🏛 Alphamed Press 🌐 English ⚖ 286 KB